Once-a-day diabetes jab launched
Updated on 07 July 2009
A new once-a-day injection for Type 2 diabetes is being launched in the UK.
The drug, Victoza (also called liraglutide), stimulates the release of insulin only when blood sugar levels become too high.
Victoza can be taken any time of day and is indicated for use in combination with other drugs, as directed by a doctor.
It has been shown to help people lose weight by increasing the "full" feeling they have and reducing the rate at which the stomach empties.
Another benefit is that it lowers blood pressure, which is a factor in people's risk of heart disease.
Many of the two million with Type 2 diabetes are overweight or obese and an estimated 500,000 more people have Type 2 but do not know it.
Cathy Moulton, care advisor at Diabetes UK, said: "Liraglutide widens the choice of treatments for people with Type 2 diabetes that not only offer improved blood glucose control but also aid weight loss.
"In addition, research has shown that this treatment has a positive effect on blood pressure levels.
"Diabetes UK welcomes safe and effective treatments that give people with diabetes choice in how to best manage their condition."
Anthony Barnett, clinical director of diabetes and endocrinology at the Heart of England NHS Foundation Trust in Birmingham, said: "With Victoza, patients with Type 2 diabetes can be confident they are controlling their blood sugar, and may benefit from weight loss. This is an important advance for patients with type 2 diabetes, many of whom are already overweight."
These news feeds are provided by an independent third party and Channel 4 is not responsible or liable to you for the same.
